Dopamine News and Research

Latest Dopamine News and Research

Green tea for Parkinson's disease

Does the consumption of green tea, widely touted to have beneficial effects on health, also protect brain cells? Authors of a new study being published in the December 15th issue of Biological Psychiatry share new data that indicates this may be the case.

14 Dec 2007

Nematodes provide clues to dopamine's role in human aging diseases

Research carried out with a paintbrush bristle, a metronome, smelly chemicals and thousands of microscopic worms called nematodes may reveal important information about human aging diseases like Parkinson's and Alzheimer's, thanks to a grant from the Ellison Medical Foundation awarded to a University at Buffalo neurobiologist.

13 Dec 2007

New model for neurodegeneration

The gradual loss of dopamine neurons is a hallmark of many neurodegenerative diseases - Parkinson's Disease chief among them.

10 Dec 2007

Nicotine has significant effects on brain GABA

There is a clear link between GABA - a chemical substance of the central nervous system that inhibits neurons in the brain - and nicotine dependence, according to a study presented at the American College of Neuropsychopharmacology (ACNP) annual meeting.

10 Dec 2007

Stable sleep patterns and regular routines may improve outcomes in bipolar disorder

Bipolar disorder, commonly known as manic-depressive disorder, is highly influenced by the circadian system - the body's internal clock - and a specific kind of psychotherapy may help decrease irregularities in the circadian system that can trigger key symptoms of bipolar disorder, according to a study presented at the American College of Neuropsychopharmacology (ACNP) annual meeting.

10 Dec 2007

Discovery of potential "getting drunk" gene

A variant of a gene involved in communication among brain cells has a direct influence on alcohol consumption in mice, according to a new study by scientists supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health (NIH), and the U.S. Army.

5 Dec 2007

Genetic markers for mental illness

Researchers have discovered natural genetic differences that might help predict the most effective antipsychotic drugs for particular patients with mental disorders such as schizophrenia, Parkinson's and drug addiction.

4 Dec 2007

Replacing dopamine cells in Parkinson's - new source of cells found

Parkinson disease (PD) is caused by the progressive degeneration of brain cells known as dopamine (DA) cells.

4 Dec 2007

Omega-3 fatty acids protect the brain against Parkinson's disease

Omega-3 fatty acids protect the brain against Parkinson's disease, according to a study by Université Laval researchers published in the online edition of the FASEB Journal, the journal of the Federation of American Societies for Experimental Biology.

27 Nov 2007

Serum carcinoembryonic antigen level can reflect adrenal adenoma

The female patient, reported on the December 7 issue 45 of World J Gastroenterology, presented a rare case, with symptoms consistent with hyperadrenocorticism and hypercatecholaminism, and also had a Cushingoid appearance.

21 Nov 2007

Peptide therapy used to prevent progression of Parkinson's

Researchers have successfully used a peptide to reverse biochemical, cellular and anatomical changes that occur in the brains of mice with Parkinson's disease (PD), and report success in preventing the disease from progression.

21 Nov 2007

Gene-based therapy successful in Parkinson's disease

Brain scans have revealed that the first gene-based therapy for Parkinson's disease was effective.

20 Nov 2007

University of Illinois at Chicago receives $2.2 million grant to develop drugs to suppress cocaine cravings

The University of Illinois at Chicago College of Pharmacy has received a $2.2 million federal grant to develop therapeutics to suppress the cravings of cocaine addicts.

19 Nov 2007

Common painkillers may prevent Parkinson's disease

Researchers in the U.S. are suggesting that painkillers such as ibuprofen and naproxen can cut the risk of Parkinson's disease by as much as 60%.

6 Nov 2007

Saint Louis University scientists identify chemical that triggers Parkinson's disease

Researchers at the Saint Louis University School of Medicine have discovered the key brain chemical that causes Parkinson's disease - a breakthrough finding that could pave the way for new, far more effective therapies to treat one of the most common and debilitating neurological disorders.

30 Oct 2007

Deep brain stimulation to treat Parkinson's makes some act irrationally

An implantable brain device meant to help Parkinson's disease patients better control their movements, has been found to have some worrying side-effects.

29 Oct 2007

Teenage smokers at risk of depression, alcohol abuse and drug use

According to American researchers smoking cigarettes may make teens more prone to depression, alcohol abuse and illegal drug use.

28 Oct 2007

Sigma-Aldrich and Oxford BioMedica win key ruling in Open Biosystems patent case

Sigma-Aldrich and Oxford BioMedica have announced that they received a key order confirming the strength and validity of intellectual property owned by Oxford BioMedica and licensed exclusively in the research field to Sigma-Aldrich.

25 Oct 2007

More evidence dopamine plays a role in obesity

A brain-imaging study of genetically obese rats conducted at the U.S. Department of Energy's Brookhaven National Laboratory provides more evidence that dopamine - a brain chemical associated with reward, pleasure, movement, and motivation - plays a role in obesity.

25 Oct 2007

Why some succumb to stress - new brain mechanism identified

Results of a new study may one day help scientists learn how to enhance a naturally occurring mechanism in the brain that promotes resilience to psychological stress.

19 Oct 2007